What is NDC 83000-110?

83000-110 is the product NDC for Gohibic (vilobelimab), Vilobelimab 10 mg/mL injection, listed with the FDA by InflaRx GmbH. It has 1 package NDC, shown above in 10- and 11-digit form.

InflaRx GmbH, NDC labeler code 83000. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Gohibic?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Gohibic NDC 83000-110 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)83000-110Labeler and product segments. Claims need a package NDC.

Product NDC at billing width83000-0110Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
83000-110-04	83000011004	4 VIAL, SINGLE-DOSE in 1 CARTON (83000-110-04) / 20 mL in 1 VIAL, SINGLE-DOSEMarketed from Apr 4, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Gohibic
Generic name (nonproprietary): vilobelimab
Active ingredients: Vilobelimab — 10 mg/mL
Dosage form: Injection
Route: Intravenous
Labeler: InflaRx GmbHNDC labeler code 83000
Product type: Prescription drug
Marketing category: Emergency use authorization
Marketing start: Apr 4, 2023
Listing expires: Dec 31, 2026
Identifiers: Product ID 83000-110_2c67a1db-151c-d067-e063-6394a90a5b06SPL ID 2c67a1db-151c-d067-e063-6394a90a5b06SPL set ID 6a571038-1f6c-4e66-937c-ddf6e2a4e30aRxCUI 2639630, 2639636UNII F5T0RF9ZJA

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N483000011004 followed by a unit qualifier and the quantity

Package 83000-0110-04. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 23, 2025.

Full label on DailyMed (opens in a new tab)

About NDC 83000-110

What is NDC 83000-110?: 83000-110 is the product NDC for Gohibic (vilobelimab), Vilobelimab 10 mg/mL injection, listed with the FDA by InflaRx GmbH. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Gohibic (Vilobelimab).
What is the active ingredient?: Vilobelimab.
Who is the labeler?: InflaRx GmbH, NDC labeler code 83000. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Gohibic?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Gohibic (Vilobelimab) NDC 83000-110